文献速递睡眠呼吸障碍慢阻肺

肥胖低通气综合征经无创通气治疗后转换为CPAP治疗的可行性

Obesity hypoventilation syndrome treated with non-invasive ventilation: Is a switch to CPAP therapy feasible?
PubMed 文献 · Respirology · 2019-10-09

这项多中心干预试验评估了稳定期肥胖低通气综合征(OHS)患者从无创通气(NIV)转换为持续气道正压(CPAP)治疗的安全性和短期疗效。42例患者中37例成功转换,71%(95%CI:55-84%)在家庭CPAP期间维持日间PaCO2≤45 mmHg,生活质量、睡眠参数和肺功能无进一步恶化,65%患者偏好CPAP长期治疗。

要点

  • 稳定期OHS患者从NIV转换为CPAP可行,多数能维持日间PaCO2≤45 mmHg。
  • 转换后生活质量、睡眠参数和肺功能无进一步恶化。
  • 自动调节CPAP结合PSG和二氧化碳监测是有效的滴定方法。

核心结论

  • 多数稳定期OHS患者从NIV转换为CPAP治疗是可行的,可显著降低医疗成本。

研究设计与样本

  • 多中心干预试验,纳入42例稳定期OHS患者,其中37例转换为CPAP治疗。

主要发现

  • 30/42例(71%,95%CI:55-84%)在家庭CPAP期间维持日间PaCO2≤45 mmHg。
  • 生活质量、睡眠参数和肺功能无进一步恶化。
  • 24例(65%)偏好CPAP作为长期治疗,平均压力13.8±1.8 mbar。
  • 7/37例被归类为CPAP失败,仅因轻度高碳酸血症(平均47.9±2.7 mmHg)。

关键数值与推荐

  • 转换前需成功接受NIV治疗≥3个月。
  • 在PSG下行自动调节CPAP整夜滴定,参数可接受后家庭固定CPAP治疗4-6周。
  • 所有患者有重度阻塞性睡眠呼吸暂停综合征病史,52%合并COPD(GOLD I/II)。

临床怎么用

  • 对稳定期OHS患者可考虑在PSG和二氧化碳监测下转换为CPAP治疗。
  • 自动调节CPAP可用于OHS患者的滴定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Obesity hypoventilation syndrome (OHS) can be treated with either continuous positive airway pressure (CPAP) or non-invasive ventilation (NIV) therapy; the device choice has important economic and operational implications. METHODS: This multicentre interventional trial investigated the safety and short-term efficacy of switching stable OHS patients who were on successful NIV therapy for ≥3 months to CPAP therapy. Patients underwent an autotitrating CPAP night under polysomnography (PSG); if the ensuing parameters were acceptable, they were sent home on a fixed CPAP for a 4-6-week period. It was hypothesized that blood gas analysis, PSG parameters and lung function tests would remain unchanged. RESULTS: A total of 42 OHS patients were recruited, of whom 37 patients were switched to CPAP therapy. All patients had a history of severe obstructive sleep apnoea syndrome; chronic obstructive pulmonary disease (COPD) (Global Initiative for Obstructive Lung Disease (GOLD) I/II) was present in 52%. Regarding the primary outcome, 30 of 42 patients (71%, 95% CI: 55-84%) maintained daytime partial pressure of carbon dioxide (PaCO2 ) levels ≤45 mm Hg after the home CPAP period. There was no further impairment in quality of life, sleep parameters or lung function. Interestingly, 24 patients (65%) preferred CPAP as their long-term therapy, despite the high pressure levels used (mean: 13.8 ± 1.8 mbar). After the CPAP period, 7 of 37 patients were categorized as CPAP failure, albeit only due to mild hypercapnia (mean: 47.9 ± 2.7 mm Hg). CONCLUSION: It is feasible to switch most stable OHS patients from NIV to CPAP therapy, a step that could significantly reduce health-related costs. The auto-adjusted CPAP device, used in combination with the analysis of the PSG and capnometry, is a valid titration method in OHS patients.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Arellano-Maric MP, Hamm C, Duiverman ML, et al. Obesity hypoventilation syndrome treated with non-invasive ventilation: Is a switch to CPAP therapy feasible? Respirology. 2019. PMID: 31597227. doi:10.1111/resp.13704

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。